An artificial intelligence start-up founded by three insiders at Memorial Sloan Kettering Cancer Center debuted with great fanfare in February, with $25 million in venture capital and the promise that it might one day transform how cancer is diagnosed.
{iframe}https://www.nytimes.com/2018/09/20/health/memorial-sloan-kettering-cancer-paige-ai.html?nl=top-stories&nlid=34889205ries&ref=headline{/iframe}